4//SEC Filing
Hamill John P. 4
Accession 0001104659-23-026159
CIK 0001781983other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:37 PM ET
Size
4.7 KB
Accession
0001104659-23-026159
Insider Transaction Report
Form 4
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Transactions
- Award
Common Stock
2023-02-27$5.25/sh+1,000$5,250→ 14,493 total
Footnotes (1)
- [F1]Effective February 13, 2023, the Issuer completed a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001716213
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:37 PM ET
- Size
- 4.7 KB